药品首页 >
专病产品 > 高血压
日本直供

Micombi Combination 替米沙坦/氢氯噻嗪

通用名称替米沙坦/氢氯噻嗪 Telmisartan /Hydrochlorothiazide
品牌名称Micombi Combination
产地|公司日本(Japan) | 日本勃林格殷格翰(Nippon Boehringer Ingelheim)
技术状态原研产品
成分|含量替40mg/氢12.5mg
包装|存储20片/盒 室温
微信客服
Xirou_Canada
微信ID
(8:00-15:00)
服务时间
通用中文 替米沙坦/氢氯噻嗪 通用外文 Telmisartan /Hydrochlorothiazide
品牌中文 品牌外文 Micombi Combination
其他名称
公司 日本勃林格殷格翰(Nippon Boehringer Ingelheim) 产地 日本(Japan)
含量 替40mg/氢12.5mg 包装 20片/盒
剂型给药 片剂口服 储存 室温
适用范围 治疗高血压
通用中文 替米沙坦/氢氯噻嗪
通用外文 Telmisartan /Hydrochlorothiazide
品牌中文
品牌外文 Micombi Combination
其他名称
公司 日本勃林格殷格翰(Nippon Boehringer Ingelheim)
产地 日本(Japan)
含量 替40mg/氢12.5mg
包装 20片/盒
剂型给药 片剂口服
储存 室温
适用范围 治疗高血压

使用说明书

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)
等待内容更新

中文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

描述

 

Micombi是血管紧张素受体阻滞剂(ARB)和利尿剂的组合药物:ARB抑制血管平滑肌血管紧张素II引起的血管收缩,降低血压,利尿剂通过抑制肾脏中的钠和水重吸收来降低尿量。血压。

通常,该药用于治疗高血压。

介绍

 

20片

特征

 

黄橙色片(直径:约8.5mm,厚度:约3.4mm)

有效成分

 

替米沙坦40mg

氢氯噻嗪12.5mg

效果/功效

 

Micombi是血管紧张素受体阻滞剂(ARB)和利尿剂的组合药物:ARB抑制血管平滑肌血管紧张素II引起的血管收缩,降低血压,利尿剂通过抑制肾脏中的钠和水重吸收来降低尿量。血压。

通常,该药用于治疗高血压。

用法/用量

 

一般来说,对于成年人,每天服用1片。严格按照说明操作。

为避免食物可能产生的影响,请始终按照定期给药时间表,即每餐前或每餐后服用药物。

对于饭前服用药物的患者,如果您错过了剂量,请尽快服用。如果几乎是下一次剂量的时间,请跳过错过的剂量并继续您的常规给药时间表。

对于饭后服用药物的患者,如果您错过了剂量,请在吃完零食后尽快服用。你不应该一次服用两剂。

如果您不小心服用超过规定的剂量,您可能会因低血压而感到头晕。在这种情况下,请立即咨询您的医生或药剂师。

除非医生指示您这样做,否则不要停止服用该药。

注意事项

 

如果您以前曾经历任何药物的任何过敏反应(瘙痒,皮疹等)。

如果您患有肝脏疾病,胆汁分泌不良或无尿,则进行透析,或有急性肾功能衰竭,体液中的钠和/或钾减少,或糖尿病。

如果您怀孕,可能怀孕或哺乳。

如果您正在服用任何其他药品。 (某些药物可能会相互作用以增强或减少药效。请注意非处方药和膳食补充剂以及其他处方药。)

 

驾驶,操作机器,在高处工作或从事其他危险活动时要小心。该药可能引起头晕和血压下降。

饮酒时要避免或小心。它可能会增强直立性低血压(头晕)。

 

放在儿童接触不到的地方。远离热源,潮湿和阳光直射。

丢弃未使用的药物。

 

禁忌

 

最常见的不良反应包括姿势性眩晕,头晕,光敏,低血压,尿频,瘙痒,荨麻疹,红斑,呼吸困难,面部冲洗和皮疹。如果出现任何这些症状,请咨询您的医生或药剂师。

下面描述的症状很少被视为括号中指示的不良反应的初始症状。如果出现任何这些症状,请立即停止服用该药并立即就医。

眼睑,嘴唇,舌头或喉咙肿胀;呼吸困难,血压下降[血管神经性水肿,过敏反应]

手和嘴唇麻木,肌肉无力,四肢麻痹[高钾血症]

感冒,呕吐,微弱[休克,晕厥,意识丧失]

倦怠,饥饿,冷汗[低血糖]

尿量减少,水肿,全身疲劳[肾功能损害]

干咳,发烧,呼吸困难(劳累时呼吸急促)[间质性肺炎]

倦怠,肌肉疼痛,棕色尿[横纹肌溶解症]

 

上述症状并未描述该药物的所有不良反应。如果您发现除上述症状之外的任何其他症状,请咨询您的医生或药剂师。

外文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

Description

Micombi is a combination drug of an angiotensin receptor blocker (ARB) and diuretic: the ARB inhibits vasoconstriction caused by angiotensin II in vascular smooth muscle to lower blood pressure and the diuretic increases urine output via inhibition of sodium and water reabsorption in the kidney to lower blood pressure.
Usually, this medicine is used in the treatment of hypertension.

Presentation

20 tablets

Feature

yellowish orange tablet (diameter: ca. 8.5mm, thickness: ca. 3.4mm)

Active Ingredients

Telmisartan 40mg
Hydrochlorothiazide 12.5mg

Effect/Efficacy

Micombi is a combination drug of an angiotensin receptor blocker (ARB) and diuretic: the ARB inhibits vasoconstriction caused by angiotensin II in vascular smooth muscle to lower blood pressure and the diuretic increases urine output via inhibition of sodium and water reabsorption in the kidney to lower blood pressure.
Usually, this medicine is used in the treatment of hypertension.

Usage/Dosage

In general, for adults, take 1 tablet, once daily. Strictly follow the instructions.
To avoid possible effects of food, always take the drug at regular dosing schedule, that is, before every meal or after every meal.
For patients taking the medicine before meals, if you miss a dose, take as soon as possible. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule.
For patients taking the medicine after meals, if you miss a dose, take as soon as possible after taking a snack. You should never take two doses at one time.
If you accidentally take more than your prescribed dose, you may feel dizzy due to hypotension. In such cases, consult with your doctor or pharmacist immediately.
Do not stop taking this medicine unless your doctor instructs you to do so.

Cautions

If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have a hepatic disorder, poor bile secretion, or anuria, are on dialysis, or have acute renal failure, reduced sodium and/or potassium in body fluid, or diabetes mellitus.
If you are pregnant, possibly pregnant or breastfeeding.
If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Use caution when driving, operating machinery, working at high places or engaging in other hazardous activities. The medicine may cause dizziness and a decrease in blood pressure.
Avoid or be careful when drinking alcohol. It may enhance orthostatic hypotension (lightheadedness).

Keep out of the reach of children. Store away from heat, moisture and direct sunlight.
Discard unused medicine.

Contraindication

The most commonly reported adverse reactions include postural vertigo, dizziness, photosensitivity, hypotension, frequent urination, itching, hives, erythema, breathing difficulty, facial flush and rash. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
swelling of the eyelids, lips, tongue, or throat; breathing difficulty, decrease in blood pressure  [angioedema, anaphylaxis]
numbness of the hands and lips, muscle weakness, paralysis of limbs [hyperkalemia]
cold sensation, vomiting, faint [shock, syncope, loss of consciousness]
lassitude, hunger, cold sweat  [hypoglycemia]
a decrease in urine volume, edema, general fatigue [renal impairment]
dry cough, fever, breathing difficulty (shortness of breath on exertion) [interstitial pneumonia]
lassitude, muscle pain, brown urine [rhabdomyolysis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.